0.5800
30-1月-25 15:45:00
15 分の遅延
株式
+0.0498
+9.39%
本日の幅
0.5210 - 0.5800
ISIN
N/A
ソース
NASDAQ
Unicycive Therapeutics Achieves Study Objective in Oxylanthanum Carbonate (OLC) Pivotal Clinical Trial
25 6 2024 06:30:00 提供 Nasdaq GlobeNewswire
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
28 5 2024 06:03:00 提供 Nasdaq GlobeNewswire